PharMerica’s Onco360 Selected as Exclusive Specialty Pharmacy Partner for UKONIQ

Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by TG Therapeutics, Inc. to be the exclusive specialty pharmacy partner for UKONIQ (umbralisib), a new oral treatment for adult patients with relapsed refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed refractory follicular lymphoma who have received at least three prior lines of systemic therapy.

On February 5, 2021, the Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein kinase CK1-epsilon.

Onco360 is a flagship specialty pharmacy brand of PharMerica Corporation (PharMerica). PharMerica is a national leader in providing comprehensive pharmacy services with a local touch. PharMerica delivers innovative pharmacy solutions and quality of care to a broad array of healthcare markets, including long-term care, senior living, hospice, IDD/behavioral health, home infusion, specialty, and hospital management.

PharMerica’s Onco360 is an Oncology Pharmacy whose clinical and dispensing model was developed specifically to meet the specialized needs of cancer patients, and the medical teams that help care for them.

In March 2019, global investment firm KKR acquired BrightSpring Health Services, one of the largest home and community-based health services providers. As part of the transaction, BrightSpring merged with PharMerica to become a leading provider of home and community-based health and pharmacy services for high-need and medically complex populations.

PharMerica’s specialty pharmacy holdings include:

  • Amerita, Inc. – provides specialty infusion, pharmaceutical and clinical services outside of the hospital – delivering comprehensive IV medication services for patients in residential care facilities or the home setting. BrightSpring acquired Advanced Home Care’s home health and specialty infusion businesses in 2020 and will join PharMerica’s Amerita division and will operate under the name Advanced Home Infusion.
  • CareMed Specialty Pharmacy – provides comprehensive specialty pharmacy services nationally and is known industry-wide for its commitment to excellence and customer service.
  • PropacPayless – as a leading specialty service pharmacy, it offers a wide range of customized pharmacy solutions.


Takeaway: Onco360’s leading market leadership positions PharMerica as a rapidly growing stakeholder in specialty pharmacy